WALTHAM, Mass., August 06, 2025--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced the launch of pHSense™ reagents, a powerful technology designed to advance internalization studies in drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback